BU receives final approval from Boston Public Health Commission.
Researchers have discovered a potential treatment target to prevent chronic kidney disease patients from developing blood clots without causing bleeding complications.
According to an editorial, the absence of inflammatory and ulcerative lesions in the colon should be the end goal of treating patients with ulcerative colitis.
Can the disease process be delayed by reducing stress granules and decreasing persistent stress response by genetically decreasing TIA1?
Researchers believe these findings support a paradigm shift in the treatment of both localized and systematic inflammatory conditions.
Research was based on the data of 54,337 African American women enrolled in Boston University’s Black Women’s Health Study.
Researchers have engineered an artificial protein that may block malignant properties of cancer cells and correct certain birth defects.
Scientists from BUSM and UCLA plan to develop noninvasive technology that can measure a person’s risk of having lung cancer.
Armed with $12 million, researchers aim for early detection of lung cancer.
Researchers caution against using antibodies to prevent transmission.